These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31117925)

  • 21. Exploring the relationship between online buyers and sellers of image and performance enhancing drugs (IPEDs): Quality issues, trust and self-regulation.
    van de Ven K; Koenraadt R
    Int J Drug Policy; 2017 Dec; 50():48-55. PubMed ID: 29028563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An island apart? Risks and prices in the Australian cryptomarket drug trade.
    Cunliffe J; Martin J; Décary-Hétu D; Aldridge J
    Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Offline constraints in online drug marketplaces: An exploratory analysis of a cryptomarket trade network.
    Norbutas L
    Int J Drug Policy; 2018 Jun; 56():92-100. PubMed ID: 29621742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crime displacement in digital drug markets.
    Ladegaard I
    Int J Drug Policy; 2019 Jan; 63():113-121. PubMed ID: 30572247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The "Darknet": The new street for street drugs.
    Pergolizzi JV; LeQuang JA; Taylor R; Raffa RB;
    J Clin Pharm Ther; 2017 Dec; 42(6):790-792. PubMed ID: 28921578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors.
    Van Hout MC; Hearne E
    Int J Drug Policy; 2017 Feb; 40():102-110. PubMed ID: 28027812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug dealing on Facebook, Snapchat and Instagram: A qualitative analysis of novel drug markets in the Nordic countries.
    Demant J; Bakken SA; Oksanen A; Gunnlaugsson H
    Drug Alcohol Rev; 2019 May; 38(4):377-385. PubMed ID: 31050051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Illuminating the dark web market of fraudulent identity documents and personal information: An international and Australian perspective.
    Devlin C; Chadwick S; Moret S; Baechler S; Rossy Q; Morelato M
    Forensic Sci Int; 2024 Oct; 363():112203. PubMed ID: 39190956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions.
    Barratt MJ; Aldridge J
    Int J Drug Policy; 2020 Sep; 83():102894. PubMed ID: 32741717
    [No Abstract]   [Full Text] [Related]  

  • 30. Darknet and bitcoin, the obscure and anonymous side of the internet in healthcare.
    Masoni M; Guelfi MR; Gensini GF
    Technol Health Care; 2016 Nov; 24(6):969-972. PubMed ID: 27472850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing the reliability and validity of risk assessment methods in Human Factors and Ergonomics.
    Hulme A; Stanton NA; Walker GH; Waterson P; Salmon PM
    Ergonomics; 2022 Mar; 65(3):407-428. PubMed ID: 34328389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forensic drug intelligence and the rise of cryptomarkets. Part I: Studying the Australian virtual market.
    Broséus J; Morelato M; Tahtouh M; Roux C
    Forensic Sci Int; 2017 Oct; 279():288-301. PubMed ID: 28927690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carfentanil on the darknet: Potential scam or alarming public health threat?
    Negri A; Townshend H; McSweeney T; Angelopoulou O; Banayoti H; Prilutskaya M; Bowden-Jones O; Corazza O
    Int J Drug Policy; 2021 May; 91():103118. PubMed ID: 33482605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studying illicit drug trafficking on Darknet markets: Structure and organisation from a Canadian perspective.
    Broséus J; Rhumorbarbe D; Mireault C; Ouellette V; Crispino F; Décary-Hétu D
    Forensic Sci Int; 2016 Jul; 264():7-14. PubMed ID: 26978791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safer scoring? Cryptomarkets, social supply and drug market violence.
    Barratt MJ; Ferris JA; Winstock AR
    Int J Drug Policy; 2016 Sep; 35():24-31. PubMed ID: 27241015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retail price as an outcome measure for the effectiveness of drug law enforcement.
    Bright DA; Ritter A
    Int J Drug Policy; 2010 Sep; 21(5):359-63. PubMed ID: 20083399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why do users continue to contribute to darknet Child Sexual Abuse Material forums? Examining social exchange, social capital, and social learning explanations using digital forensic artifacts.
    Blokland A; Daser A; de Boer M; Gannon C; Gnielka F; Huikuri S; Reichel R; Shäfer T; Schmidt AF; Staciwa K; Lehmann R
    Child Abuse Negl; 2024 Jul; 153():106815. PubMed ID: 38735124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical systems thinking and the future role of computational modelling in ergonomics: an exploration of agent-based modelling.
    Holman M; Walker G; Lansdown T; Hulme A
    Ergonomics; 2020 Aug; 63(8):1057-1074. PubMed ID: 31724486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding Australian methylamphetamine drug markets through relational, temporal and spatial analyses.
    Popovic A; Morelato M; Baechler S; De Grazia A; Tahtouh M; Roux C; Beavis A
    Drug Test Anal; 2022 Mar; 14(3):481-495. PubMed ID: 34655507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets.
    Aldridge J; Décary-Hétu D
    Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.